Advisory Board

Regius Professor of Precision Medicine at the Beatson Cancer Institute at the University of Glasgow. Former Director of the Center for Personalised Cancer Therapeutics at Mount Sinai, New York.

Head of Data Science at Project Rōnin. Co-founded a software company that developed novel machine learning / AI methods for clinical trials (acquired by Medidata Solutions). Developed the algorithms behind two validated genomic diagnostic tests.

Neuro & Medical Oncologist, Beverly Hills Cancer Center. Expertise in immunotherapy of cancer and precision medicine. Recognised as one of Top Doctors in America by US News & World Report.

Deputy Chief Medical Officer, Director Breast Program, Chief of Breast Surgery, Yale Cancer Center, Smilow Cancer Hospital. Professor of Surgery, Yale School of Medicine.

Medical Director of Oncology-Hematology, Novartis Oncology Region Europe, Paris. Notable expertise in anti-cancer drugs.

Gastrointestinal Oncology Consultant, Addenbrooke’s Hospital, Cambridge. Research focus on clinical trials and translational research in gastroesophageal cancer. Elected secretary of EORTC GI clinical trials group 2018-2021.

Consultant in Medical Oncology, focus on Gastrointestinal Oncology, Klinik Arlesheim (Canton of Basel), Switzerland.

Professor of Medical Oncology, Institute of Immunology and Immunotherapy, University of Birmingham. Gary sits on the Lung CSG, the NCRI advanced colorectal sub-group, the NCRI pancreatic sub-group and CTAAC.

Extensive experience in venture capital, supporting the development of deep tech and IoT companies globally.